Endo International

Endo International plc is a global specialty pharmaceutical company focused on improving the lives of patients while creating value. Endo develops, manufactures, markets and distributes quality branded and generic pharmaceutical products as well as over-the-counter medications through our operating companies – Endo Pharmaceuticals, Par Pharmaceutical, Paladin Labs, SOMAR and Litha. Endo commenced operations in 1997 by acquiring certain pharmaceutical products, related rights and assets from The DuPont Merck Pharmaceutical Company. Since that time, the company has expanded to include the following business segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals and International Pharmaceuticals. Endo’s strategy is to maximize value for our key stakeholders by employing an efficient operating model with focused and disciplined execution that allows us to pursue growth opportunities both organically and through selective acquisitions. Additionally, we are leveraging a research and development model that focuses on lower risk, near-term projects. Our goal is to consistently create value for our shareholders while serving our patients and customers. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, Pennsylvania. We employ approximately 6,000 people worldwide.
Ballsbridge, IE

Endo International Locations

Ballsbridge, IE
Cranbury Township, US
Horsham, US
Horsham, US
Horsham, US
Rye, US
Eden Prairie, US
Chestnut Ridge, US
Chestnut Ridge, US
Huntsville, US
Huntsville, US
Charlotte, US
Charlotte, US
Suffern, US
Irvine, US
Rochester, US
Stratford, US
Watford, GB
Chennai, IN
Kelambakkam, IN

Endo International Metrics

Endo International Summary

Founding Date


Market capitalization

$4.64 B

Closing share price


Endo International Market Value History

Endo International Online Presence

Endo International News

Endo International Company Life